Johnson and Johnson’s Ortho Biotech has informed the FDA of preliminary safety findings from a clinical trial conducted in Germany investigating the use of Procrit (epoetin alfa) to treat acute ischemic stroke. The clinical trial utilised doses of Procrit that were considerably higher than the doses recommended for the treatment of anemia as described in [...]
Entries Tagged as 'Food and Drug Administration'
Procrit linked to deaths in stroke patients
October 1st, 2008 · No Comments · Epoetin alfa, FDA, Food and Drug Administration, competitive intelligence, pharma, strategy
Tags: